- Research article
- Open Access
- Open Peer Review
Effect of maternal calcium intake during pregnancy on children's blood pressure: A systematic review of the literature
© Bergel and Barros; licensee BioMed Central Ltd. 2007
- Received: 12 June 2006
- Accepted: 26 March 2007
- Published: 26 March 2007
Calcium supplementation during pregnancy has been shown to reduce the incidence of hypertension in the mother, but the effects on the offspring are uncertain. Assessing the impact on the offspring is very important given the now large body of evidence indicating that blood pressure levels in childhood and young adulthood can be influenced by factors operating during fetal life. We conducted a systematic review of the literature to summarize the evidence supporting an association between maternal dietary calcium intake during pregnancy and blood pressure in the offspring.
A systematic review was performed to identify randomized, quasi-randomized and cohort studies reporting the relationship between offspring blood pressure or incidence of hypertension and levels of maternal dietary calcium intake during pregnancy, either from supplements (i.e. pills) or food. MEDLINE, EMBASE and the Cochrane Library Registry were searched for relevant trials.
Two randomized trial and three observational studies were identified and included in this review. In 4 of the 5 studies, loss to follow-up was a serious concern. There was heterogeneity between the studies, particularly those conducted on children below 12 month of age. Results were more consistent among the studies including older children (1 to 9 years) where a higher maternal calcium intake was associated with a reduction of -1.92 mm Hg (95% CI -3.14 to -0.71) in offspring systolic blood pressure. One large randomized trial found a clinically and statistically significant reduction in the incidence of hypertension in 7-year-old children (RR = 0.59, 95% CI 0.39 to 0.90).
There is evidence in the literature to support an association between maternal calcium intake during pregnancy and offspring blood pressure. However, more research is needed to confirm these finding given the small sample sizes and the methodological problems in many of the studies conducted so far. More studies on populations with calcium deficit are also needed. If confirmed, these findings could have important public health implications. Calcium supplementation during pregnancy is simple and inexpensive and may be a way to reduce the risk of hypertension and its sequels in the next generation.
- Calcium Intake
- Calcium Supplementation
- Blood Pressure Level
- Dietary Calcium Intake
- Oral Calcium Supplementation
Increased dietary calcium intake has been associated with lower blood pressure among children, adults and pregnant women [1, 2]. The effect seems to be more evident among individuals with low calcium intake [3–6]. Some recent experimental and observational studies in humans and animals have reported an association between maternal calcium intake during pregnancy and blood pressure in the offspring [5, 6], but others have not [1, 7]. These findings follow a large body of evidence indicating that blood pressure levels in childhood and young adulthood are influenced by factors operating early in life [7–10] and are associated with later cardiovascular disease and mortality . We conducted a systematic review and meta-analysis of studies reporting blood pressure levels in offspring of mothers who were either enrolled in a trial of calcium supplementation during pregnancy or included in a study on maternal calcium intake during the index pregnancy.
Types of studies
This review includes randomized and quasi-randomized controlled trials. We pre-specified that if the evidence from randomized trials was insufficient (i.e. small trials, trials of bad quality, etc.) to assess the effect of the intervention, then data from observational studies (e.g. cohort studies) would be considered for inclusion. Studies with historical controls and ecological studies were excluded, as the data provided by these are unreliable for determining causation and/or association.
Studies should provide an estimate of the incidence of hypertension, or the mean difference in offspring blood pressure between levels of maternal calcium dietary intake during pregnancy, or should enable this information to be computed from data extracted from the article.
Types of participants
Offspring of mothers included in studies assessing the association between calcium intake during pregnancy and offspring blood pressure.
Types of intervention or exposure
Maternal dietary calcium intake during pregnancy, from supplements (i.e. pills) or food.
Types of outcome measures
Offspring diastolic and systolic blood pressure in mm Hg; incidence of hypertension.
Search strategy for identification of studies
1. MEDLINE and EMBASE (1966 to 2005) were searched in December 2005 using the following search strategy
#1 Search calcium [Title] 84110
#2 Search pregnan* 568541
#3 Search "blood pressure" 247471
#4 Search hyperten* 241702
#5 Search #1 AND #2 AND (#3 OR #4) 253
2. All databases included in The Cochrane Library (issue 4, 2005) were searched with a search strategy equivalent to the Medline strategy.
3. Reference lists of all the studies that went into the pool of retrieved studies, including those of other reviews, were examined to identify any further studies. We did not implement a standardized strategy to find unpublished studies.
Selection of studies and data extraction
The titles, abstracts and descriptor terms of all material downloaded from the electronic searches were read and irrelevant reports were discarded. All citations identified were then inspected to establish the relevance of the article according to the inclusion criteria. Where there was uncertainty about relevance, the full article was obtained. Studies were reviewed for relevance on the basis of study design, types of participants, exposures and outcome measures. Standardized data extraction forms were used, one for clinical trials and one for cohort/cross-sectional studies. The following characteristics were extracted from each study included:
a) Administrative details: identification; author(s); published or unpublished; year of publication; year in which study was conducted; details of other relevant papers cited.
b) Details of study: study design; method(s) of recruitment; inclusion and exclusion criteria; number of participants assessed for eligibility, number excluded, number enrolled, number analyzed; type, duration, frequency and completeness of follow-up in the case of cohort studies; country and location of the study.
c) Characteristics of participants: age; location; details of intervention.
d) Crude and adjusted measures of effect, confidence intervals and p-values were extracted. When an adjusted analysis was performed, type of analysis and the list of covariates adjusted for were recorded.
e) The amount of maternal calcium intake was extracted and reported as the amount of elemental calcium in mg.
Details of analysis
One study  did not report regression coefficients, but reported the correlation coefficient between maternal calcium intake and offspring blood pressure. Standard errors for the correlation coefficients were computed using the Fisher r-to-z transformation . The correlation coefficients were transformed to standardized mean differences and multiplied by blood pressure standard deviation to estimate the effect .
The meta-analysis was conducted using the Revman computer software package . The amount of heterogeneity between studies was assessed by a formal statistical test (chi-square test), and by I2 . The chi-squared test assesses whether observed differences between results are compatible with chance alone . A low p-value provides evidence of heterogeneity of treatment effects . The results of the chi-squared test might be misleading because it has low power for trials with small sample size, and I2 has been proposed as an additional tool for assessing heterogeneity . I2 describes the percentage variability in effect estimates that is due to heterogeneity rather than sampling error (chance) and is not affected by the number of trials in the meta-analysis . A value greater than 50% may be considered substantial heterogeneity. Mathematically, it is defined as I2 = [(Q - df)/Q] × 100%, where Q is the chi-squared statistic and df is the number of degrees of freedom [18, 19].
Quality of randomized controlled trials was assessed following the method described in the Cochrane Collaboration Handbook . For observational studies, quality was assessed following the recommendations of the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines .
Characteristics of randomized controlled trials included in the review.
Numbered, sealed opaque envelopes, containing randomization codes.
Numbered treatment packs in computer-generated simple randomization sequence.
Lost to follow-up – women
Of 593 (calcium) vs. 601 (placebo) enrolled, 14 vs. 13 were lost before starting treatment and excluded from analysis; 577 vs. 588 had at least partial follow up. Follow up was incomplete for 52 vs. 46, but delivery data were available in 17 vs. 12 of these, giving delivery data for 544 vs. 554.
calcium 132/2,295 vs. placebo 121/2,294.
Lost to follow-up – offspring
Of 614 randomized in one center (calcium 309/placebo 305), 301/299 completed the first study, 2/6 infant deaths and 1/0 maternal deaths had occurred, leaving 298/293 eligible for follow up. 289/285 were contacted, 10/5 refused to participate, 22/19 lived outside the country, and 257/261 were assessed.
559 randomized in study site. Of 497 invited to participate in the follow-up study, BP was measured in 260 infants at 3 months of age and 57 toddlers at 2 years of age.
Nulliparous women, < 20 weeks pregnant; blood pressure < 140/90 mmHg (mean of 5 measurements); no present or past disease; not taking medication; normal oral glucose tolerance tests.
Pregnant nulliparas (45% black, 35% non-Hispanic white, 17% Hispanic white). Passed compliance test (took 75% of placebo over 6–14 days); BP 134/84 mmHg or less; urine protein dipstick negative or trace; 13–21 weeks pregnant.
Exclusion criteria: taking medications; obstetric or pre-existing diseases or personal characteristics which could influence study end-points, absorption or metabolism of calcium; any risk associated with calcium supplementation, or compliance; elevated serum creatinine (1.0 mg per decilitre or more) or calcium (10.6 mg per decilitre or more); renal disease; haematuria; history or family history of urolithiasis; frequent use of calcium supplements or antacids.
Of 11,959 women screened, 5,703 excluded initially and a further 1,667 after the compliance test. The remaining 4,589 women were enrolled.
Two public and one private hospital participated in the original trial, but only babies born in the private hospital were included in the follow-up study at 7 years of age.
Five participating medical centers participated in the original trial, but only babies born in one center (Oregon) were included in the follow-up study. Additional criteria for inclusion: mothers who completed the original trial, delivered an infant without serious problems, and who read english. Follow-up was completed at 12 week postpartum and at 2 years of age.
2 g calcium as 500 mg calcium carbonate tablets, vs. identical looking placebo tablets. Compliance was 84% (calcium) and 86% (placebo).
2 g/day elemental calcium as calcium carbonate, or placebo. Taken until delivery, development of pre-eclampsia or suspicion of urolithiasis. All women took 50 mg calcium per day as normal supplementation and were asked to drink 6 glasses of water per day.
Compliance was 64% in the calcium group and 67% in the placebo group. 20% of women took > 90% of the allocated treatment.
Systolic blood pressure, diastolic blood pressure, kidney stones, gall stones, hospital admissions
Systolic blood pressure, left ventricular wall mass. Diastolic blood pressure was measured at 2 years but group means were not reported.
Hatton et al.  randomized 4,589 women during early pregnancy to either 2000 grams of oral calcium supplementation or placebo. A detailed clinical and laboratory evaluation was conducted before trial entry, and women with complications during pregnancy or signs or history of calcium metabolism disorders were excluded. Furthermore, a baseline compliance test was used to exclude women with low compliance before trial entry. Two follow-up studies were conducted at 3 and 24 months post-partum. Patients from only one out of five medical centers were included in the follow-up (559 out 4589 subjects). Randomization was stratified by center, but no data are available on the baseline characteristics of the follow-up sample. Loss to follow-up was 53% at 3 months and 90% at 2 years. The authors acknowledge this to be a problem, adding that that a large proportion of the cohort had not reached two years of age by the end of the study. This is the main methodological limitation of this study. Sample size is also an issue, given the small number remaining for analysis. Calcium intake from other sources (i.e. prenatal supplements, diet) in the population from Belizan et al.  was estimated at 600 mg per day, well below the recommended level during pregnancy. In contrast, the reported calcium intake for the population in Hatton et al.  was over 1200 mg per day, within recommended levels. In summary, the two randomized trials included [21, 22] were similar in respect of the characteristics of the intervention, study design and inclusion criteria, but differed in an important population characteristic (baseline calcium intake); also, loss to follow-up was a problem in one study .
Characteristics of observational studies included in the review.
Rhode Island, USA
Age at Follow-up
At birth – 1 month – 6 month – 12 month
212 – 184 – 114 – 70
Systolic and diastolic blood pressure
Systolic blood pressure
Systolic and diastolic blood pressure, insulin, fasting glucose, triacylglicerol, cholesterol (total, HDL and LDL)
Average maternal calcium intake during pregnancy (mg/day)
Total:1494 first trimester (FT), 1330 second trimester (ST). From prenatal supplements: 264 (FT), 203 (ST). From food: 1230 (FT), 1128 (ST).
Maternal prenatal diet assessed postpartum in hospital by a 116 item semi quantitative food frequency questionnaire.
Maternal diet assessment with a semi quantitative food frequency questionnaire validated in pregnancy during the first trimester and second trimester. Analysis stratified by calcium from food and calcium from prenatal supplements.
Mothers of all live born twins in Tasmania were approached soon after birth. They were asked whether they had taken any nutritional supplements during pregnancy.
Exposure categories, maternal calcium intake in mg
Quartiles (1380, 1722, 2048) and correlation coefficients
Quartiles (Q4 - Q1 = 424 mg) and linear regression
Maternal calcium supplements during pregnancy (yes/no). Calcium content of supplements not stated.
Blinding of exposure status and ascertainment of outcome.
Lost to follow-up or invalid exclusions
Total eligible population not stated. 212 mothers with prenatal dietary data included. Lost to follow-up by age at follow-up (%): 0 13 46 67
2128 total population. 462 missing maternal diet assessment, 232 did not consent, 381 did not attend follow-up visits, 77 outcome missing, 39 missing covariates.
Total eligible population not stated. 463 twin children recruited. 11had co-twin not available for recruitment. 23 pairs left Tasmania. 14 pairs could not be traced and 42 declined to participate.
Cuff size, observer, sleep/activity status. Age in days (At birth), body weight (at 6 and 12 month). Maternal race, parents education and occupation. Dietary potassium and magnesium
Energy intake, BP measurement conditions (cuff size, infant position, appendage used, machine model, infant state, clinic site)
Maternal age and education, twin pair birth order (in family), child age at assessment and sex. Study in twins.
Maternal race, education, number of previous pregnancies, marital status, pregnancy body mass index and third trimester systolic blood pressure. Infant age and sex.
Study reported two sets of results, for calcium from food and from prenatal supplements.
Study in twins.
Gillman et al.  used the data from a cohort study of pregnant women conducted in the US. This study was designed to assess the effects of mother's diet on mother's and offspring's health. It assessed maternal calcium intake during the first and second trimesters using a validated semi-quantitative FFQ, and measured offspring blood pressure at birth and at 6 months. The authors reported figures for calcium from food sources and from prenatal supplements, and then performed two independent analyses accordingly. This seems to have been a non-pre-specified analysis. The strength of the evidence for this analysis is not clear because it was not stated whether this analysis strategy was pre-specified .
Morley et al.  used the data from a population-based survey in Tasmania designed to investigate sudden infant death syndrome. Mothers of all live-born twins during the study period were approached after birth for data collection, including nutritional supplement consumption during pregnancy. Data on calcium consumption from other sources (i.e. foods) were not available. Children were assessed at a mean age of 9 years and blood pressure was measured.
All three studies were conducted in developed countries, and average calcium intake was higher than the recommended calcium intake during pregnancy for the two studies with quantitative estimates [12, 23].
It is not clear whether outcome assessment in any of the three observational studies was blinded to levels of exposure. Loss to follow-up was large (see table 2 for details). One of the studies  conducted follow-ups at 4 time points, but the sample size decreased for older infants. Less than 40% of the sample was available in the last follow-up at 1 year of age. The authors reported that one of the primary reasons for the decrease in sample size with age was that not all infants had reached 1 year by the end of the study.
All three observational studies attempted to adjust for confounding variables, but they differed markedly in the set of variables included. Two of them adjusted for blood pressure measurement conditions [12, 23]. All three adjusted for socioeconomic factors (e.g. maternal education) and child age at assessment. One  reported estimates from more than one model, including one adjusted for dietary potassium and magnesium. Crude and adjusted estimates were similar in all three studies, suggesting that confounding was not a problem in exploring this association.
A funnel plot was produced to assess publication bias . Because of the small number of studies, the figure was not very informative and was not included in this report. Publication bias cannot be excluded.
In summary, all five studies seem to have been well conducted. The main limitation in all the observational studies was loss to follow-up. For two of these studies, small sample size was also a problem. In one study, the focus of the analysis was a sub-group analysis.
In the largest randomized trial  there was a modest, statistically insignificant effect on systolic blood pressure, but a clinically and statistically significant effect on the incidence of high systolic blood pressure at 7 years of age (see table 3). This study also reported that the effect is stronger among overweight children; this was not observed by others, though the sample sizes were too small to exclude such a difference.
Maternal calcium intake during pregnancy and blood pressure in the offspring. Summary of results from observational studies.
Age at follow-up
Maternal calcium intake (mg)
Offspring blood pressure in mm Hg, by quartiles of maternal calcium intake
Crude effect size (95%CI)‡
Adjusted effect size (95% CI)*
Systolic blood pressure (mm Hg)
-0.84 (-3.69 to 2.01)
-6.13 (-9.32 to -2.94)
-4.28 (-7.12 to -1.44)
-3.84 (-7.81 to 0.13)
-3.08 (-6.66 to 0.50)
-0.30 (-1.29 to 0.69)
-0.04 (-1.10 to 1.00)
-3.10 (-4.78 to -1.42)
-3.00 (-4.90 to -1.10)
-4.28 (-8.94 to 0.38)
-3.40 (-8.40 to 1.69)
-0.80 (-4.17 to 2.57)
-0.70 (-4.20 to 2.70)
Diastolic blood pressure (mm Hg)
0.21 (-2.64 to 3.06)
-0.95 (-3.72 to 1.82)
-1.91 (-4.96 to 0.87)
-5.89 (-9.95 to -1.83)
-4.28 (-7.90 to -0.66)
-4.80 (-9.39 to -0.01)
-5.19 (-10.37 to 0.01)
-0.80 (-2.80 to 1.20)
-0.90 (-2.90 to 1.10)
Maternal calcium intake during pregnancy and blood pressure in the offspring. Summary of results from the long term follow-up of randomized controlled trials.
Age at follow-up
Mean Difference (95%CI)
Systolic Blood Pressure (mm Hg)
-1.4 (-3.2 to 0.5)
-4.8 (-9.2 to -0.3)
-2.2 (-5.5 to 1.1)
Diastolic Blood Pressure (mm Hg)
-0.4 (-2.0 to 1.2)
Relative Risk (95%CI)
High Blood Pressure – systolic
0.59 (0.39 to 0.90)
High Blood Pressure – diastolic
0.80 (0.49 to 1.30)
This systematic review of the literature identified two randomized trials and three observational studies. The evidence provided by this body of research suggests an association between dietary calcium intake during pregnancy and offspring blood pressure. A good quality randomized trial found a large reduction in the incidence of hypertension in children at 7 years of age . However, the same trial found a smaller effect on blood pressure as a continuous variable. A possible explanation for these findings is that the intervention produced a change in the shape of the blood pressure distribution, as opposed to a shift in mean blood pressure.
A meta-analysis that combined four studies on children over one year of age found a reduction in mean systolic blood pressure. This finding should be viewed with caution, since evidence obtained by combining small studies has previously been shown to be unreliable because of publication bias . For infants under one year of age the evidence is contradictory and difficult to summarize.
Among the 5 studies reported, only two were randomized trials. The validity of the evidence from observational studies for assessing the effect of interventions is controversial . The two randomized trials included in the review were multi-center trials and the randomization was stratified by center. The authors chose to follow up subjects from only one center. It can be assumed that because the randomization was stratified by center, the effect estimate will not be biased. However, an impact on external validity can be expected. For example, in one study, participants from the selected hospital were of higher socioeconomic status than those from the centers not included in the follow-up . Apart for the methodological problems of the original articles, other limitations of this analysis should be pointed out. Four out of the five studies included in the review were conducted in developed countries, and on populations in which maternal calcium intake was adequate or even higher than the recommended levels during pregnancy. This is clearly not the ideal target for a nutritional intervention. Given the evidence that the effect of calcium might be apparent only when there is a deficit, the external validity of these results might be compromised .
The heterogeneity between studies also creates difficulties for interpreting the results. The sources and dose of dietary calcium vary widely among the observational studies, and so do the methods used to assess the amount consumed. There are also large differences between studies in infants' ages at assessment. It is well known that the determinant of blood pressure varies with age, and it has been shown that the impact of factors affecting the fetal environment are seen particularly after adolescence . This problem is magnified because of the difficulties in measuring blood pressure accurately at early ages .
In summary, there is evidence in the literature to support an association between maternal calcium intake during pregnancy and offspring blood pressure. However, more research is needed to confirm these findings, given the small sample sizes and the methodological problems of many of the studies conducted so far. New evidence should be derived from the long-term follow-up of large and well-conducted randomized trials of calcium supplementation during pregnancy. More studies on populations with calcium intake deficit are also needed. Assessing the effect of the intervention on other cardiovascular risk factors would also be an asset for future research. Calcium supplementation during pregnancy is simple and inexpensive, and if these findings are confirmed it could be a way to prevent hypertension and its sequels in the next generation.
The authors wish to thank Margarete Marques for her support for the collaborative activities during the conduct of this research.
- Van Mierlo LA, Arends LR, Streppel MT, Zeegers MP, Kok FJ, Grobbee DE, Geleijnse JM: Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens. 2006, 20: 571-580. 10.1038/sj.jhh.1002038.View ArticlePubMedGoogle Scholar
- Carroli G, Duley L, Belizan JM, Villar J: Calcium supplementation during pregnancy: a systematic review of randomised controlled trials. Br J Obstet Gynaecol. 1994, 101: 753-758.View ArticlePubMedGoogle Scholar
- Gillman MW, Hood MY, Moore LL, Nguyen US, Singer MR, Andon MB: Effect of calcium supplementation on blood pressure in children. J Pediatr. 1995, 127: 186-192. 10.1016/S0022-3476(95)70293-8.View ArticlePubMedGoogle Scholar
- Gillman MW, Oliveria SA, Moore LL, Ellison RC: Inverse association of dietary calcium with systolic blood pressure in young children. JAMA. 1992, 267: 2340-2343. 10.1001/jama.267.17.2340.View ArticlePubMedGoogle Scholar
- Atallah AN, Hofmeyr GJ, Duley L: Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2002, CD001059-Google Scholar
- Dwyer JH, Dwyer KM, Scribner RA, Sun P, Li L, Nicholson LM, Davis IJ, Hohn AR: Dietary calcium, calcium supplementation, and blood pressure in African American adolescents. Am J Clin Nutr. 1998, 68: 648-655.PubMedGoogle Scholar
- Stary HC: Lipid and macrophage accumulations in arteries of children and the development of atherosclerosis. Am J Clin Nutr. 2000, 72: 1297S-1306S.PubMedGoogle Scholar
- Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998, 338: 1650-1656. 10.1056/NEJM199806043382302.View ArticlePubMedGoogle Scholar
- Zinner SH, Rosner B, Oh W, Kass EH: Significance of blood pressure in infancy. Familial aggregation and predictive effect on later blood pressure. Hypertension. 1985, 7: 411-416.PubMedGoogle Scholar
- Zinner SH, Martin LF, Sacks F, Rosner B, Kass EH: A longitudinal study of blood pressure in childhood. Am J Epidemiol. 1974, 100: 437-442.PubMedGoogle Scholar
- McCarron P, Smith GD, Okasha M, McEwen J: Blood pressure in young adulthood and mortality from cardiovascular disease. Lancet. 2000, 355: 1430-1431. 10.1016/S0140-6736(00)02146-2.View ArticlePubMedGoogle Scholar
- McGarvey ST, Zinner SH, Willett WC, Rosner B: Maternal prenatal dietary potassium, calcium, magnesium, and infant blood pressure. Hypertension. 1991, 17: 218-224.View ArticlePubMedGoogle Scholar
- Hays W: Statistics. Edited by: 4. 1988, New York: Holt, Rinehart & WinstonGoogle Scholar
- Rosenthal R: Meta-Analytic Procedures for Social Research. 1984, Beverly Hills, CA: SageGoogle Scholar
- Review Manager (RevMan) [Computer program]. Version 4.2.8 for Windows. 2005, Oxford, England: The Cochrane CollaborationGoogle Scholar
- Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21: 1539-1558. 10.1002/sim.1186.View ArticlePubMedGoogle Scholar
- Higgins J, Green S, editors: Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. 2005, The Cochrane Library. Chichester, UK: John Wiley & Sons, LtdGoogle Scholar
- Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ. 2003, 327: 557-560. 10.1136/bmj.327.7414.557.View ArticlePubMedPubMed CentralGoogle Scholar
- Higgins J, Thompson S, Deeks J, Altman D: Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy. 2002, 7: 51-61. 10.1258/1355819021927674.View ArticlePubMedGoogle Scholar
- Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283: 2008-2012. 10.1001/jama.283.15.2008.View ArticlePubMedGoogle Scholar
- Belizan JM, Villar J, Bergel E, del Pino A, Di Fulvio S, Galliano SV, Kattan C: Long-term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial [see comments]. BMJ. 1997, 315: 281-285.View ArticlePubMedPubMed CentralGoogle Scholar
- Hatton DC, Harrison-Hohner J, Coste S, Reller M, McCarron D: Gestational calcium supplementation and blood pressure in the offspring. Am J Hypertens. 2003, 16: 801-805. 10.1016/S0895-7061(03)01027-6.View ArticlePubMedGoogle Scholar
- Gillman MW, Rifas-Shiman SL, Kleinman KP, Rich-Edwards JW, Lipshultz SE: Maternal calcium intake and offspring blood pressure. Circulation. 2004, 110: 1990-1995. 10.1161/01.CIR.0000143199.93495.96.View ArticlePubMedPubMed CentralGoogle Scholar
- Morley R, Carlin JB, Dwyer T: Maternal calcium supplementation and cardiovascular risk factors in twin offspring. Int J Epidemiol. 2004Google Scholar
- Belizan JM, Villar J, Gonzalez L, Campodonico L, Bergel E: Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med. 1991, 325: 1399-1405.View ArticlePubMedGoogle Scholar
- Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000, 355: 1064-1069. 10.1016/S0140-6736(00)02039-0.View ArticlePubMedGoogle Scholar
- Egger M, Davey SG, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315: 629-634.View ArticlePubMedPubMed CentralGoogle Scholar
- Egger M, Smith GD: Bias in location and selection of studies. BMJ. 1998, 316: 61-66.View ArticlePubMedPubMed CentralGoogle Scholar
- Huxley RR, Shiell AW, Law CM: The role of size at birth and postnatal catchup growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens. 2000, 18: 815-831. 10.1097/00004872-200018070-00002.View ArticlePubMedGoogle Scholar
- O'Brien E, Beevers G, Lip GY: ABC of hypertension. Blood pressure measurement. Part III-automated sphygmomanometry: ambulatory blood pressure measurement. BMJ. 2001, 322: 1110-1114. 10.1136/bmj.322.7294.1110.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/7/15/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.